| SEQ_NO | 1 | Date of announcement | 2025/05/13 | Time of announcement | 18:25:27 |
| Subject | The Phase II clinical trial results of the innovative drug SNS812 have been selected for oral presentation at the 2025 ATS International Conference. | ||||
| Date of events | 2025/05/20 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2025/05/20 2.Company name:Microbio (Shanghai) Co.,Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Subsidiary 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence: (1)The broad-spectrum antiviral small nucleic acid drug SNS812,co-developed by Microbio (Shanghai) and Oneness Biotech, has been selected for oral presentation at the Mini Symposium of the 2025 American Thoracic Society (ATS) International Conference, in recognition of its innovative mechanism and significant clinical efficacy. The presentation will present the latest clinical trial results of SNS812. (2)The 2025 American Thoracic Society (ATS) International Conference will be held in San Francisco, USA. The oral presentation of SNS812 is scheduled for May 20, 2025, at 6:03 AM Taiwan time. 6.Countermeasures:None 7.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): (1)The ATS International Conference is the most influential academic event in the field of respiratory medicine worldwide. It covers three major areas: pulmonary disease, critical care, and sleep medicine. Each year, the conference attracts approximately 14,000 participants from around the globe, including clinicians, researchers, nurses, respiratory therapists, other healthcare professionals, and industry representatives in the fields of pulmonary, critical care, and sleep medicine. The event focuses on the latest scientific research, clinical innovations, and global public health challenges. (2)The presentation materials can be found on the Market Observation Post System (MOPS) under the Oneness Biotech ”Investor Conferences” section. |
||||
